Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -138.09% is 77% below its 5-year average of -78.00%, near the high end of its 5-year range (-515.39%–20.72%).
50.52% above its 12-month average of -279.10%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -292.88%.
EBITDA MARGIN
-138.09%
EBITDA MARGIN AVG TTM
-279.10%
EBITDA MARGIN AVG 3Y
-88.39%
EBITDA MARGIN AVG 5Y
-78.00%
EBITDA MARGIN AVG 10Y
-184.55%
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+50.52%
CURRENT VS 3Y AVG
-56.23%
CURRENT VS 5Y AVG
-77.03%
CURRENT VS 10Y AVG
+25.18%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
MediWound Ltd.
Market Cap
$171.77M
EBITDA Margin
-138.09%
TTM Avg
-279.10%
3Y Avg
-88.39%
5Y Avg
-78.00%
Market Cap
$172.79M
EBITDA Margin
-6455.53%
TTM Avg
-6455.53%
3Y Avg
-6455.53%
5Y Avg
-6455.53%
Market Cap
$170.72M
EBITDA Margin
-83.89%
TTM Avg
-252.72%
3Y Avg
-1380.70%
5Y Avg
-1383.45%
Market Cap
$170.03M
EBITDA Margin
-144.16%
TTM Avg
-87.79%
3Y Avg
-115.19%
5Y Avg
-149.65%
Market Cap
$169.48M
EBITDA Margin
-18889.15%
TTM Avg
-9445.90%
3Y Avg
-9445.90%
5Y Avg
-9445.90%
Market Cap
$178.54M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$163.00M
EBITDA Margin
-416.41%
TTM Avg
-228.13%
3Y Avg
-163.44%
5Y Avg
-116.60%
Market Cap
$180.32M
EBITDA Margin
-6.19%
TTM Avg
-12.15%
3Y Avg
-13.37%
5Y Avg
-13.97%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MediWound Ltd. (MDWD) | $171.77M | -138.09% | -279.10% | -88.39% | -78.00% |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.79M | -6455.53% | -6455.53% | -6455.53% | -6455.53% |
| Cue Biopharma, Inc. (CUE)vs › | $170.72M | -83.89% | -252.72% | -1380.70% | -1383.45% |
| Precision BioSciences, Inc. (DTIL)vs › | $170.03M | -144.16% | -87.79% | -115.19% | -149.65% |
| Nkarta, Inc. (NKTX)vs › | $169.48M | -18889.15% | -9445.90% | -9445.90% | -9445.90% |
| Canton Strategic Holdings Inc (CNTN)vs › | $178.54M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | -416.41% | -228.13% | -163.44% | -116.60% |
| Journey Medical Corporation (DERM)vs › | $180.32M | -6.19% | -12.15% | -13.37% | -13.97% |
| Inogen, Inc. (INGN)vs › | $157.47M | -2.74% | -4.58% | -13.60% | -7.28% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | N/A | N/A | N/A | N/A |
Gross Margin
15.5%
EBITDA Margin
-138.1%
Operating Margin
-149.1%
Net Margin
-170.1%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -292.88% |
| 2026-03-31 | -515.39% |
| 2025-12-31 | -381.52% |
| 2025-09-30 | -112.49% |
| 2025-06-30 | -93.24% |
| 2025-03-31 | -123.06% |
| 2024-12-31 | -97.36% |
| 2024-09-30 | -108.38% |
| 2024-06-30 | -81.51% |
| 2024-03-31 | -67.81% |
| 2023-12-31 | -66.47% |
| 2023-09-30 | -56.24% |
| 2023-06-30 | -77.35% |
| 2023-03-31 | -106.90% |
| 2022-12-31 | 20.72% |
| 2022-09-30 | -54.66% |
| 2022-06-30 | -71.66% |
| 2022-03-31 | -67.23% |
| 2021-12-31 | -59.14% |
| 2021-09-30 | -40.00% |
| 2021-06-30 | -42.53% |
| 2021-03-31 | -28.19% |
| 2020-12-31 | -32.40% |
| 2020-09-30 | -18.34% |
| 2020-06-30 | -60.47% |
| 2020-03-31 | -43.67% |
| 2019-12-31 | -52.24% |
| 2019-09-30 | -47.20% |
| 2019-06-30 | 68.52% |
| 2019-03-31 | -716.92% |
| 2018-12-31 | 545.36% |
| 2018-09-30 | -244.52% |
| 2018-06-30 | -302.23% |
| 2018-03-31 | -688.27% |
| 2017-12-31 | -639.06% |
| 2017-09-30 | -361.16% |
| 2017-06-30 | -517.76% |
| 2017-03-31 | -649.44% |
| 2016-12-31 | -1000.93% |
| 2016-09-30 | -928.76% |
| 2016-06-30 | -1845.51% |
| 2016-03-31 | -1527.95% |
| 2015-12-31 | -2500.75% |
| 2015-09-30 | -4159.80% |
| 2015-06-30 | -3303.64% |
| 2015-03-31 | -6497.01% |
| 2014-12-31 | -5240.32% |
| 2014-09-30 | -11028.26% |
| 2014-06-30 | -12856.41% |
| 2014-03-31 | -8700.00% |
